HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC label Study B participants: nearly two-thirds are under 45, one-fifth over 55.

This article was originally published in The Rose Sheet

Executive Summary

FDA OTC LABEL STUDY PARTICIPANTS: TWO-THIRDS UNDER AGE 45, so that as the OTC drug and cosmetics/drug industries begin to analyze and comment on the survey results, the age range of the participants may become a sticking point in determining how generalizable the data are. The Cosmetic, Toiletry and Fragrance Association, for example, notes in Oct. 6 comments on FDA's proposal to revise OTC drug labels that a separate consumer preference and comprehension study to be conducted by the agency (Study C) lacks a "sufficient sample" of elderly consumers ("The Rose Sheet" Oct. 6, 1997, p. 10).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel